Session » Vasculitis Poster I

Date: Sunday, November 8, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 885

a Retrospective Analysis of Low Dose Cyclophosphamide Therapy in Systemic Vasculitides

9:00AM-11:00AM: Abstract Number: 865

Abdominal Visceral Adipose Tissue Measured By Dual Energy X-Ray Absorptiometry (DXA) As a Novel Surrogate Marker of Cardiovascular Risk in Primary Necrotizing Vasculitides

9:00AM-11:00AM: Abstract Number: 881

ANCA Associated Vasculitis with Hypocomplementemia Has More Diffuse Alveolar Hemorrhage and a Poor Prognosis

9:00AM-11:00AM: Abstract Number: 861

ANCA-Associated Pauci-Immune Glomerulonephritis: ¿Always Pauci-Immune?

9:00AM-11:00AM: Abstract Number: 890

Anti-IgE Monoclonal Antibody in Refractory and/or Relapsing Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss): Data from 17 Patients

9:00AM-11:00AM: Abstract Number: 864

Anticytokine Autoantibody Profiling in Five Types of Systemic Vasculitis

9:00AM-11:00AM: Abstract Number: 892

Autoimmune Associated Orbital Inflammatory Masses and Response to Immunosuppressive Therapy

9:00AM-11:00AM: Abstract Number: 889

Central Nervous System Involvement of Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss): Retrospective Analysis of 26 Cases and Review of the Literature

9:00AM-11:00AM: Abstract Number: 871

Clinicians’ Perspective on Aspects of ANCA-Associated Vasculitis That Influence Patients’ Function and General Health: A Delphi Exercise Based on the International Classification of Function, Disability and Health

9:00AM-11:00AM: Abstract Number: 863

Contribution of MPO-/PR3-ANCA Tests to the Diagnosis of ANCA-Associated Vasculitis in a Community Hospital: Evaluation of 2,782 Samples

9:00AM-11:00AM: Abstract Number: 876

Damage Develops Early and Is Common in Children with Chronic Systemic Vasculitis

9:00AM-11:00AM: Abstract Number: 870

Development of an Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Patient-Reported Outcome Measure: Identification of Salient Themes and Candidate Questionnaire Item Development

9:00AM-11:00AM: Abstract Number: 875

Differences in Early Damage Patterns in Various Forms of Primary Systemic Vasculitis

9:00AM-11:00AM: Abstract Number: 879

Diffuse Alveolar Hemorrhage Secondary to ANCA-Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes

9:00AM-11:00AM: Abstract Number: 862

Discriminative Performance of Nasal Endoscopic Findings and History Items in Patients with Granulomatosis with Polyangiitis

9:00AM-11:00AM: Abstract Number: 856

Elderly Versus Younger Patients with ANCA-Associated Vasculitis

9:00AM-11:00AM: Abstract Number: 893

Epidemiological Features of Childhood IgA Vasculitis (Henoch-Schönlein) in a French County: A Population-Based Survey

9:00AM-11:00AM: Abstract Number: 853

Evaluation and Validation of Case-Finding Algorithms for the Identification of Patients with Granulomatosis with Polyangiitis in Large Healthcare Administrative Databases

9:00AM-11:00AM: Abstract Number: 883

Evaluation of Thiopurine Metabolites Monitoring in Patients Treated with Azathioprine for Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 880

Extra-Corporeal Membrane Oxygenation and Diffuse Alveolar Haemorrhage: A Single Centre Case Series and Analysis of the ELSO Database

9:00AM-11:00AM: Abstract Number: 866

High Rate and Bimodal Pattern of Severe Infection in a Selected ANCA Associated Vasculitis Cohort

9:00AM-11:00AM: Abstract Number: 877

Improved Survival in Granulomatosis with Polyangiitis: A Population-Based Study

9:00AM-11:00AM: Abstract Number: 887

Intravenous Immunoglobulin As Immunomodulating Agent in ANCA-Associated Vasculitides: A French Nationwide Study of 92 Patients

9:00AM-11:00AM: Abstract Number: 894

Late-Onset IgA Vasculitis in Adult Patients Exhibits Distinct Clinical Characteristics and Outcomes

9:00AM-11:00AM: Abstract Number: 891

Long-Term Use of Rituximab for Eosinophilic Granulomatosis with Polyangiitis

9:00AM-11:00AM: Abstract Number: 882

Lung Damage in ANCA Associated Vasculitis Assessed By Vasculitis Damage Index: Recurrent Pulmonary Infections Have a Significant Contribution

9:00AM-11:00AM: Abstract Number: 869

Lymphoma in Patients with Granulomatosis with Polyangiitis

9:00AM-11:00AM: Abstract Number: 854

Nationwide Incidence of Anti Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis in Iceland

9:00AM-11:00AM: Abstract Number: 860

Neutrophil/Lymphocyte Ratio: Could It be a Prognostic Indicator for Renal Outcome in Patients with Granulomatosis with Polyangiitis?

9:00AM-11:00AM: Abstract Number: 884

Patient Perceptions of Treatment with Glucocorticoids in ANCA-Associated Vasculitis

9:00AM-11:00AM: Abstract Number: 888

Plasma Exchanges to Treat Primary Systemic Necrotizing Vasculitides: Data from a French Nationwide Study

9:00AM-11:00AM: Abstract Number: 859

Predictors of Renal Histopathology in Antineutrophil Cytoplasmic Antibody Associated Glomerulonephritis

9:00AM-11:00AM: Abstract Number: 857

Prognosis Value of Geriatric Assessment Scales in Older Adults with New Onset ANCA-Associated Vasculitis: A Pilot Retrospective Study

9:00AM-11:00AM: Abstract Number: 895

Relapses and Predictive Factors in Henoch-SchÖnlein Purpura. study of 417 Patients

9:00AM-11:00AM: Abstract Number: 868

Risk Factors for Cytomegalovirus Reactivation in Patients with Antineutrophil Cytoplasmic Antibody -Associated Vasculitis

9:00AM-11:00AM: Abstract Number: 886

Rituximab As a Cyclophosphimide Sparing Agent for Patients with Multi-Relapsing Antineutrophil Cytoplasmic Antibody Associated Small Vessel Vasculitis

9:00AM-11:00AM: Abstract Number: 855

Seasonality in ANCA-Associated Vasculitis

9:00AM-11:00AM: Abstract Number: 878

Significance of Interstitial Pneumonitis in Microscopic Polyangiitis

9:00AM-11:00AM: Abstract Number: 867

Simultaneous Measurement of 25-Hydroxyvitamin D and Procalcitonin in Granulomatosis with Polyangiitis (GPA): Differentiation of Activity from Infection?

9:00AM-11:00AM: Abstract Number: 858

Stimulated Renal Glomerular Endothelial Cells Were Damaged By Fiber-like NETs Released By Neutrophils in ANCA-Associated Vasculitis

9:00AM-11:00AM: Abstract Number: 873

The ANCA-Vasculitis Index of Damage (AVID): Performance of a New Damage Instrument

9:00AM-11:00AM: Abstract Number: 874

The Short Term Damage Burden in Vasculitis and Vasculitis Mimics As Measured By the Vasculitis Damage Index

9:00AM-11:00AM: Abstract Number: 872

Work Limitations and Disability in Patients with Systemic Vasculitis

« View all sessions from this meeting